Custom service

Biotinylated Peptides

Biotinylate peptides at the terminus or a side chain, with or without spacers

Turnaround: 2–4 weeksTypical scale: 0.5 mg – 1 g modified peptideChemistry options: N-terminal and Lys biotinylation; PEG-spacer (LC- and Mini-) biotin options; desthiobiotin and Strep-tag variants

Biotinylated Peptides supports programmes that biotinylate peptides at the terminus or a side chain, with or without spacers. In a typical engagement we plan the N-terminal and Lys biotinylation route first, confirm compatibility with PEG-spacer (LC- and Mini-) biotin options, and release biotinylated peptide with biotin-ratio assay on a 2–4 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep N-terminal and Lys biotinylation as the primary option and hold PEG-spacer (LC- and Mini-) biotin options in reserve, so that scale-up never depends on an unproven step.

Streptavidin capture and plate-coating workflows

Pull-down and biophysical binding assays

Biotinylated material at GMP grade

Modifications requiring radiological or BSL-3 containment

Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.

Service Highlights

  • N-terminal and Lys biotinylation as the default route, with PEG-spacer (LC- and Mini-) biotin options held as a proven fallback
  • Desthiobiotin and Strep-tag variants worked into the design where the application requires it
  • Modification sites are mapped on the sequence and confirmed by MS/MS before release
  • Analytical confirmation of every intermediate before the final release
  • Modified and unmodified species are separated and quantified, not just reported
  • Biotinylated peptide with biotin-ratio assay delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence & modification map

    We annotate every modification site, protection strategy and analytical target before synthesis starts.

  2. Solid-phase assembly

    The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.

  3. Modification chemistry

    Post-synthesis steps — N-terminal and Lys biotinylation, PEG-spacer (LC- and Mini-) biotin options — are run under conditions validated on a test cleavage.

  4. Cleavage & purification

    Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.

  5. Analytical release

    Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.

  6. Documentation

    Biotinylated peptide with biotin-ratio assay is released with the batch record and analytical package after QC sign-off.

Specifications & timeline

Turnaround
2–4 weeks
Typical scale
0.5 mg – 1 g modified peptide
Chemistry options
N-terminal and Lys biotinylation; PEG-spacer (LC- and Mini-) biotin options; desthiobiotin and Strep-tag variants
Deliverable
Biotinylated peptide with biotin-ratio assay
QC package
HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
Shipping
Ambient or blue ice as stability data dictate

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.